Telo Genomics Corp.
TELO.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.97% | 23.00% | 13.26% | -34.21% | -8.27% |
| Total Depreciation and Amortization | 615.00% | -4.76% | 5.00% | -13.04% | -42.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -45.76% | -- | -- |
| Change in Net Operating Assets | 21.56% | 85.03% | 135.92% | -277.68% | 150.43% |
| Cash from Operations | 29.87% | 34.25% | 52.16% | -139.39% | 15.43% |
| Capital Expenditure | -700.00% | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -10,560.00% | -- | 100.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 99.77% | -109,900.00% |
| Cash from Financing | -- | -- | 100.00% | -100.02% | 1,661,700.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -42.40% | 33.80% | 52.34% | -150.78% | 500.03% |